Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | RAB9A | P51151 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | CLK1 | P49759 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | SNCA | P37840 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24071620 | 0.94 | NPC1 (0.67) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL24071592 | 0.86 | RAB9A (0.69) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL24071510 | 0.84 | NPC1 (0.67) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL25199236 | 0.83 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL25197014 | 0.83 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL31200612 | 0.82 | RAB9A (0.64) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL31419731 | 0.82 | RAB9A (0.64) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL24071507 | 0.82 | NPC1 (0.67) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL24071501 | 0.82 | NPC1 (0.70) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL24071505 | 0.82 | NPC1 (0.63) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203025-A1 | ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A | Sanford Burnham Prebys Medical Discovery Institute | 2023-06-29 | — | — | US | disclosed |
| US-20230203025-A1 | ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A | Sanford Burnham Prebys Medical Discovery Institute | 2023-06-29 | — | — | US | disclosed |
| WO-2021243230-A1 | ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2021-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203025-A1 | ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A | GPR119, GUCY1A2, PRKG1 | NPC1 224/4885RAB9A 1329/4885SMN1; SMN2 1583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.